Lineage Cell Therapeutics, Inc.·4

Mar 17, 5:00 PM ET

Hogge Gary S. 4

4 · Lineage Cell Therapeutics, Inc. · Filed Mar 17, 2021

Insider Transaction Report

Form 4
Period: 2021-03-15
Hogge Gary S.
SVP,Clinical & Medical Affairs
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2021-03-15+419,500419,500 total
    Exercise: $2.43Exp: 2031-03-15Common Shares (419,500 underlying)
Footnotes (1)
  • [F1]One quarter of the options shall vest on March 15, 2022 and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.

Documents

1 file
  • 4
    ownership.xmlPrimary